S2-E16.2 - Future Directions for NASH Cost-Effectiveness Research
Send us Fan Mail Mazen Noureddin and Stephen Harrison discuss future directions cost-effectiveness research in and outside the U.S. might take, while the Surfers consider the implications. In respons...
27 Mar 202114min
S2 E16.1 -- How Cost-Effectiveness Research On Widespread NIT Screening In The U.S. Has Evolved
Send us Fan Mail Mazen Noureddin describes how he became engaged in studying the cost-effectiveness of widespread NASH screening for diabetics in the US, and what he has found, while the Surfers comme...
27 Mar 202117min
S2-E16 -- Cost-Effectiveness of Widespread Non-Invasive NASH Testing and Treatment
Send us Fan Mail Mazen Noureddin joins the Surfers to discuss his work determining cost effectiveness of Non-Invasive Testing in Type 2 diabetics and the broader population. The discussion shifts to c...
25 Mar 202154min
S2-E15 — Wrapping Up NASH-TAG 2021
Send us Fan Mail Surfing the NASH Tsunami closes the book on NASH-TAG 2021 by considering highlights and major themes of the conference. The conversation focuses on the dramatic increase in disease kn...
18 Mar 202152min
S2-E14 - NASH-TAG Session 4 Summary: Basic Science and Promising Drugs on the Horizon
Send us Fan Mail Naim Alkhouri and Jörn Schattenberg join Roger and Donna to review the closing session of NASH-TAG 2021, a potpourri of basic science and review of promising drugs earlier in developm...
15 Mar 202147min
S2-E13 - NASH-TAG Session 3 Summary: Trial Designs of the Future and the Future of Diabetes Drugs in NASH
Send us Fan Mail NASH-TAG Co-director Michael Charlton and Ian Rowe join Roger, Louise and Donna to review the morning that Michael himself identified as one of two highlight sessions of NASH-TAG 2021...
14 Mar 202149min
S2-E12 - NASH-TAG Session 2 Summary: Innovative Trial Design and Robust Histologic Analyses
Send us Fan Mail Jörn Schattenberg and Naim Alkhouri join the Surfers (including NASH-TAG co-director Stephen Harrison) to review NASH-TAG session to with its focus on innovative trial design and impr...
13 Mar 202148min
S2 E11 — NASH-TAG Session 1 summary: Major Drugs in Development and Why Trials Fail
Send us Fan Mail Manal Abdelmalek and Ian Rowe join Roger, Louise and Donna to review the morning that Vlad Ratziu and Michael Charlton both identified as the highlight session of NASH-TAG 2021. The...
12 Mar 202150min
